Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop

被引：4

作者：

Gavin, James R. ^{[1
]}

Rodbard, Helena W. ^{[2
]}

Battelino, Tadej ^{[3
,4
]}

Brosius, Frank ^{[5
]}

Ceriello, Antonio ^{[6
]}

Cosentino, Francesco ^{[7
,8
]}

Giorgino, Francesco ^{[9
,10
]}

Green, Jennifer ^{[11
]}

Ji, Linong ^{[12
]}

Kellerer, Monika ^{[13
]}

Koob, Susan ^{[11
,14
]}

Kosiborod, Mikhail ^{[12
,13
,15
,16
,17
,18
]}

Lalic, Nebojsa ^{[19
]}

Marx, Nikolaus ^{[20
]}

Nedungadi, T. Prashant ^{[21
]}

Parkin, Christopher G. ^{[22
]}

Topsever, Pinar ^{[23
]}

Ryden, Lars ^{[24
]}

Sheu, Wayne Huey-Herng ^{[25
]}

Standl, Eberhard ^{[26
]}

Vandvik, Per Olav ^{[27
]}

Schnell, Oliver ^{[26
]}

机构：

[1] Emory Univ, Sch Med, Atlanta, GA USA

[2] Endocrine & Metab Consultants, 3200 Tower Oaks Blvd,Suite 250, Rockville, MD 20852 USA

[3] Univ Ljubljana, Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[4] Univ Ljubljana, Fac Med, Ljubljana, Slovenia

[5] Univ Arizona, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA

[6] IRCCS Multimed, Via Milanese 300, I-20099 Sesto San Giovanni, MI, Italy

[7] Karolinska Inst, Dept Med, Cardiol Unit, Solna, Stockholm, Sweden

[8] Karolinska Univ Hosp, Solna, Stockholm, Sweden

[9] Univ Bari Aldo Moro, Dept Precis & Regenerat Med, Bari, Italy

[10] Univ Bari Aldo Moro, Sect Internal Med Endocrinol Androl & Metab Dis, Ionian Area, Bari, Italy

[11] Duke Univ, Med Ctr, Duke Clin Res Inst, 641 Durham Ctr,Box 17969, Durham, NC 27715 USA

[12] Peking Univ Peoples Hosp, 11 Xizhimen S St, Beijing, Peoples R China

[13] Marienhosp Stuttgart, Boheimstr 37, D-70199 Stuttgart, Germany

[14] PCNA Natl Off, 613 Williamson St, Suite 200, Madison, WI 53703 USA

[15] St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA

[16] Univ Missouri, 4401 Wornall Rd, Kansas City, MO 64111 USA

[17] George Inst Global Hlth, Sydney, Australia

[18] Univ New South Wales, Sydney, Australia

[19] Univ Belgrade, Univ Clin Ctr Serbia, Pasterova 2, Beograd 11000, Serbia

[20] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Pauwelsstr 30, D-52074 Aachen, Germany

[21] Amer Heart Assoc, 7272 Greenville Ave, Dallas, TX 75082 USA

[22] CGParkin Commun Inc, 2675 Windmill Pkwy,Suite 2721, Henderson, NV 89074 USA

[23] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Family Med, Kayisdagi Cd 3, TR-34752 Icerenkoy, Atasehir Istanb, Turkiye

[24] Karolinska Inst, Dept Med K2, Stockholm, Sweden

[25] Natl Res Hlth Inst, Inst Mol & Genom Med, Zhunan 350, Miaoli, Taiwan

[26] Forschergrp Diabet eV, Ingolstaedter Landstr 1, Munich, Germany

[27] Univ Oslo, Lovisenberg Diaconal Hosp, Inst Hlth & Soc, Dept Med, Lovisenberggata 17, N-0456 Oslo, Norway

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2024年 / 211卷

关键词：

Continuous glucose monitoring; CGM; Real-time CGM; rtCGM; Intermittently scanned CGM; isCGM; Type; 1; diabetes; 2; HbA1c; Ambulatory glucose profile; AGP; SELF-RATED HEALTH; QUALITY-OF-CARE; SOCIOECONOMIC-STATUS; STRUCTURAL RACISM; UNITED-STATES; ETHNIC DISPARITIES; HEART-FAILURE; IMPLICIT BIAS; PHYSICIANS; RISK;

D O I：

10.1016/j.diabres.2024.111666

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is a mounting clinical, psychosocial, and socioeconomic burden worldwide as the prevalence of diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD) continues to rise. Despite the introduction of therapeutic interventions with demonstrated efficacy to prevent the development or progression of these common chronic diseases, many individuals have limited access to these innovations due to their race/ethnicity, and/ or socioeconomic status (SES). However, practical guidance to providers and healthcare systems for addressing these disparities is often lacking. In this article, we review the prevalence and impact of healthcare disparities derived from the above-mentioned chronic conditions and present broad-based recommendations for improving access to quality care and health outcomes within the most vulnerable populations.

引用

页数：7

共 50 条

[31] Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshop
Markham-Lee, Zoe
Bhagat-Jones, Swati
Carlton, Jill
Frankel, Andrew
Fraser, Simon
Habte-Asres, Hellena H.
Hill, Claire
Kanumilli, Naresh
Karalliedde, Janaka
Maskell, Annelie
Mcknight, Amy Jayne
Morris, Anna
Nitsch, Dorothea
Otake John, Nia
Parks, Steven
Robinson, Sarah Jane
Rosenthal, Miranda
Rutter, Martin K.
Schmutz, Caroline
Scullion, Shawna
Smith, Rachel
Tarm, Linda
Wheeler, David C.
Newman, Daniel
Mistry, Sanjay
Mccafferty, Kieran
Hills, Claire E.
DIABETIC MEDICINE, 2025,
[32] Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD
Jung, Chan-Young
Heo, Ga Young
Park, Jung Tak
Joo, Young Su
Kim, Hyung Woo
Lim, Hyunsun
Chang, Tae Ik
Kang, Ea Wha
Yoo, Tae-Hyun
Kang, Shin-Wook
Lee, Joongyub
Kim, Soo Wan
Oh, Yun Kyu
Jung, Ji Yong
Oh, Kook-Hwan
Ahn, Curie
Han, Seung Hyeok
CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (07) : 1116 - 1127
[33] Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD
Chan-Young Jung
Ga Young Heo
Jung Tak Park
Young Su Joo
Hyung Woo Kim
Hyunsun Lim
Tae Ik Chang
Ea Wha Kang
Tae-Hyun Yoo
Shin-Wook Kang
Joongyub Lee
Soo Wan Kim
Yun Kyu Oh
Ji Yong Jung
Kook-Hwan Oh
Curie Ahn
Seung Hyeok Han
Clinical Research in Cardiology, 2021, 110 : 1116 - 1127
[34] Chronic kidney disease, cardiovascular outcomes, and treatment disparities following non-ST elevation myocardial infarction
Mecla, Jessica L.
Scirica, Benjamin M.
Qin, Jie
Gibson, C. Michael
Morrow, David A.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A220 - A220
[35] Chronic Kidney Disease Prevalence and Outcomes in Patients with Type 2 Diabetes or Prediabetes at High Cardiovascular Risk: Results from the CINEMA Program
Datla, Sanjana
Albar, Zainab
Eaton, Elke
Porges, Jodie
Nennstiel, Matthew
Sullivan, Claire
Greene, Lloyd
Al-Kindi, Sadeer
Padiyar, Aparna
Rahman, Mahboob
Rajagopalan, Sanjay
Neeland, Ian
CIRCULATION, 2024, 150
[36] OUTCOMES ASSOCIATED WITH NONCONCORDANCE TO NATIONAL KIDNEY FOUNDATION GUIDELINE RECOMMENDATIONS FOR ORAL ANTIDIABETIC DRUG TREATMENTS IN PATIENTS WITH CONCOMITANT TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Chen, Shih-Yin
Lee, Yuan-Chi
Alas, Veronica
Greene, Mallik
Brixner, Diana
ENDOCRINE PRACTICE, 2014, 20 (03) : 221 - 231
[37] Chronic kidney disease and cardiovascular disease in diabetes melitus in a county from western Romania
Schiller, Adalbert
Munteanu, Mircea
Taranu, Mihaela
Posta, Norica
Mihaescu, Adelina
Radu, Luiza
Ionutiu, Lavinia
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 90 - 91
[38] Prevalence of diabetes in Mexico. Results from the national survey of chronic diseases (NSCD).
Rios, JM
Rull, JA
Olaiz, G
Rojas, R
GomezPerez, F
Valles, V
Tapia, R
Sepulveda, J
DIABETES, 1996, 45 : 1035 - 1035
[39] Prevalence and impact of diabetes, hypertension, and cardiovascular diseases in chronic obstructive pulmonary diseases: A hospital-based cross-section study
Mahishale, Vinay
Angadi, Naveen
Metgudmath, Vijayanand
Eti, Ajith
Lolly, Mitchelle
Khan, Sujeer
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2015, 3 (04) : 155 - 160
[40] Prevalence of Chronic Kidney Diseases in Patients with Diabetes Mellitus in the Middle East: A Systematic Review and Meta-Analysis
Naser, Abdallah Y.
Alwafi, Hassan
Alotaibi, Basil
Salawati, Emad
Samannodi, Mohammed
Alsairafi, Zahra
Alanazi, Abeer F. R.
Dairi, Mohammad S.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021

← 1 2 3 4 5 →